The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 27, 2023 | Margolin Yael | Director | Disposed to issuer(D) | 2K | — | — |
| Dec 27, 2023 | Margolin Yael | Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Margolin Yael | Director | Disposed to issuer(D) | 26K | — | — |
| Dec 27, 2023 | Margolin Yael | Director | Disposed to issuer(D) | 45K | — | — |
| Dec 27, 2023 | Silber Allan C | Executive Chairman, Director | Disposed to issuer(D) | 7K | — | — |
| Dec 27, 2023 | Silber Allan C | Executive Chairman, Director | Disposed to issuer(D) | 332K | — | — |
| Dec 27, 2023 | Silber Allan C | Executive Chairman, Director | Disposed to issuer(D) | 537K | — | — |
| Dec 27, 2023 | Demers William L. | Chief Financial Officer | Disposed to issuer(D) | 179K | — | — |
| Dec 27, 2023 | Demers William L. | Chief Financial Officer | Disposed to issuer(D) | 131K | — | — |
| Dec 27, 2023 | Demers William L. | Chief Financial Officer | Disposed to issuer(D) | 105K | — | — |
| Dec 27, 2023 | Demers William L. | Chief Financial Officer | Disposed to issuer(D) | 17K | — | — |
| Dec 27, 2023 | Lubner David Charles | Director | Disposed to issuer(D) | 4K | — | — |
| Dec 27, 2023 | Lubner David Charles | Director | Disposed to issuer(D) | 26K | — | — |
| Dec 27, 2023 | Lubner David Charles | Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Lubner David Charles | Director | Disposed to issuer(D) | 45K | — | — |
| Dec 27, 2023 | Malik Rajesh | Director | Disposed to issuer(D) | 45K | — | — |
| Dec 27, 2023 | Malik Rajesh | Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Malik Rajesh | Director | Disposed to issuer(D) | 26K | — | — |
| Dec 27, 2023 | Hogue Gerald L. | Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Hogue Gerald L. | Director | Disposed to issuer(D) | 45K | — | — |
| Dec 27, 2023 | Hogue Gerald L. | Director | Disposed to issuer(D) | 26K | — | — |
| Dec 27, 2023 | Hogue Gerald L. | Director | Disposed to issuer(D) | 18K | — | — |
| Dec 27, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Disposed to issuer(D) | 84K | — | — |
| Dec 27, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Disposed to issuer(D) | 60K | — | — |
| Dec 27, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Jensen Jessica D. | EVP Clinical Development | Disposed to issuer(D) | 126K | — | — |
| Dec 27, 2023 | Jensen Jessica D. | EVP Clinical Development | Disposed to issuer(D) | 14K | — | — |
| Dec 27, 2023 | Jensen Jessica D. | EVP Clinical Development | Disposed to issuer(D) | 213K | — | — |
| Dec 27, 2023 | Jensen Jessica D. | EVP Clinical Development | Disposed to issuer(D) | 136K | — | — |
| Dec 27, 2023 | Jensen Jessica D. | EVP Clinical Development | Disposed to issuer(D) | 461K | — | — |
| Dec 27, 2023 | McCann Joe A. | Chief Executive Officer, Director | Disposed to issuer(D) | 693K | — | — |
| Dec 27, 2023 | McCann Joe A. | Chief Executive Officer, Director | Disposed to issuer(D) | 382K | — | — |
| Dec 27, 2023 | Kelly Justyna | Chief Operating Officer | Disposed to issuer(D) | 5K | — | — |
| Dec 27, 2023 | Kelly Justyna | Chief Operating Officer | Disposed to issuer(D) | 70K | — | — |
| Dec 27, 2023 | Kelly Justyna | Chief Operating Officer | Disposed to issuer(D) | 78K | — | — |
| Dec 27, 2023 | Kelly Justyna | Chief Operating Officer | Disposed to issuer(D) | 98K | — | — |
| Dec 27, 2023 | Kelly Justyna | Chief Operating Officer | Disposed to issuer(D) | 27K | — | — |
| Dec 27, 2023 | Goodman Jonathan R. | Director | Disposed to issuer(D) | 26K | — | — |
| Dec 27, 2023 | Goodman Jonathan R. | Director | Disposed to issuer(D) | 25K | — | — |
| Dec 27, 2023 | Goodman Jonathan R. | Director | Disposed to issuer(D) | 45K | — | — |
| Dec 27, 2023 | Goodman Jonathan R. | Director | Disposed to issuer(D) | 36K | — | — |
| Dec 26, 2023 | Lubner David Charles | Director | Tender(U) | 35K | — | — |
| Dec 26, 2023 | Malik Rajesh | Director | Tender(U) | 4K | — | — |
| Dec 26, 2023 | Hogue Gerald L. | Director | Tender(U) | 22K | — | — |
| Dec 26, 2023 | Goodman Jonathan R. | Director | Tender(U) | 42K | — | — |
| Dec 22, 2023 | Silber Allan C | Executive Chairman, Director | Tender(U) | 314K | — | — |
| Dec 22, 2023 | Silber Allan C | Executive Chairman, Director | Tender(U) | 4.3M | — | — |
| Dec 22, 2023 | Silber Allan C | Executive Chairman, Director | Tender(U) | 72K | — | — |
| Dec 22, 2023 | Silber Allan C | Executive Chairman, Director | Tender(U) | 38K | — | — |
| Dec 22, 2023 | Silber Allan C | Executive Chairman, Director | Tender(U) | 4.0M | — | — |
| Dec 22, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Tender(U) | 2.8M | — | — |
| Dec 22, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Tender(U) | 358 | — | — |
| Dec 22, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Tender(U) | 233K | — | — |
| Dec 22, 2023 | McCann Joe A. | Chief Executive Officer, Director | Tender(U) | 2K | — | — |
| Dec 22, 2023 | McCann Joe A. | Chief Executive Officer, Director | Tender(U) | 3.5M | — | — |
| Dec 18, 2023 | BVF Inc | Insider | Sell(S) | 896K | $12.45 | $11.2M |
| Dec 18, 2023 | BVF Inc | Insider | Sell(S) | 7.3M | $12.45 | $90.8M |
| Dec 18, 2023 | BVF Inc | Insider | Sell(S) | 9.0M | $12.45 | $111.7M |
| Nov 6, 2023 | McCann Joe A. | Chief Executive Officer, Director | Gift(G) | 120K | — | $0 |
| Nov 3, 2023 | Silber Allan C | Executive Chairman, Director | Gift(G) | 500K | — | $0 |
| Oct 31, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Gift(G) | 250K | — | $0 |
| Jun 13, 2023 | Martell Bridget A | Director | Grant(A) | 81K | — | $0 |
| Jun 1, 2023 | Lubner David Charles | Director | Grant(A) | 45K | — | $0 |
| Jun 1, 2023 | Malik Rajesh | Director | Grant(A) | 45K | — | $0 |
| Jun 1, 2023 | Margolin Yael | Director | Grant(A) | 45K | — | $0 |
| Jun 1, 2023 | Goodman Jonathan R. | Director | Grant(A) | 45K | — | $0 |
| Jun 1, 2023 | Hogue Gerald L. | Director | Grant(A) | 45K | — | $0 |
| Mar 28, 2023 | Demers William L. | Chief Financial Officer | Grant(A) | 131K | — | $0 |
| Mar 28, 2023 | Fleshner Neil E. | Chief Medical Officer, Director | Grant(A) | 84K | — | $0 |
| Mar 28, 2023 | Jensen Jessica D. | EVP Clinical Development | Grant(A) | 136K | — | $0 |
| Mar 28, 2023 | Kelly Justyna | Chief Operating Officer | Grant(A) | 98K | — | $0 |
| Mar 28, 2023 | McCann Joe A. | Chief Executive Officer, Director | Grant(A) | 693K | — | $0 |
| Mar 28, 2023 | Silber Allan C | Executive Chairman, Director, 10% Owner | Grant(A) | 537K | — | $0 |
| Mar 21, 2023 | Hogue Gerald L. | Director | Option exercise(M) | 18K | $6.97 | $125K |
| Mar 21, 2023 | Hogue Gerald L. | Director | Option exercise(M) | 18K | — | $0 |
| Nov 29, 2022 | McCann Joe A. | Chief Executive Officer, Director | Buy(P) | 2K | $6.64 | $14K |
| Nov 28, 2022 | Malik Rajesh | Director | Buy(P) | 4K | $6.66 | $25K |
| Nov 25, 2022 | Hogue Gerald L. | Director | Buy(P) | 4K | $6.82 | $25K |
| Nov 23, 2022 | Lubner David Charles | Director | Buy(P) | 4K | $6.85 | $25K |
| Nov 21, 2022 | Margolin Yael | Director | Buy(P) | 2K | $6.56 | $11K |
| Nov 18, 2022 | Silber Allan C | Executive Chairman, Director, 10% Owner | Buy(P) | 22K | $6.50 | $146K |
| Nov 18, 2022 | Goodman Jonathan R. | Director | Buy(P) | 6K | $6.33 | $38K |
| Nov 17, 2022 | Silber Allan C | Executive Chairman, Director, 10% Owner | Buy(P) | 28K | $6.00 | $166K |
| Jun 2, 2022 | Goodman Jonathan R. | Director | Grant(A) | 26K | — | $0 |
| Jun 2, 2022 | Hogue Gerald L. | Director | Grant(A) | 26K | — | $0 |
| Jun 2, 2022 | Lubner David Charles | Director | Grant(A) | 26K | — | $0 |
| Jun 2, 2022 | Margolin Yael | Director | Grant(A) | 26K | — | $0 |
| Jun 2, 2022 | Malik Rajesh | Director | Grant(A) | 26K | — | $0 |
| May 25, 2022 | Fleshner Neil E. | Chief Medical Officer, Director | Sell(S) | 564K | $7.51 | $4.2M |
| Apr 1, 2022 | Jensen Jessica D. | EVP Clinical Development | Grant(A) | 14K | — | $0 |
| Mar 29, 2022 | Jensen Jessica D. | EVP Clinical Development | Grant(A) | 213K | — | $0 |
| Mar 29, 2022 | Kelly Justyna | Chief Operating Officer | Grant(A) | 78K | — | $0 |
| Mar 29, 2022 | Silber Allan C | Executive Chairman, Director, 10% Owner | Grant(A) | 332K | — | $0 |
| Mar 29, 2022 | Demers William L. | Chief Financial Officer | Grant(A) | 105K | — | $0 |
| Mar 29, 2022 | Fleshner Neil E. | Chief Medical Officer, Director | Grant(A) | 60K | — | $0 |
| Mar 29, 2022 | McCann Joe A. | Chief Executive Officer, Director | Grant(A) | 382K | — | $0 |
| Dec 9, 2021 | Kelly Justyna | Chief Operating Officer | Grant(A) | 70K | — | $0 |
| Jul 6, 2021 | Margolin Yael | Director | Grant(A) | 25K | — | $0 |
| Jul 6, 2021 | Malik Rajesh | Director | Grant(A) | 25K | — | $0 |
| Jul 6, 2021 | Lubner David Charles | Director | Grant(A) | 25K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).